Show Summary Details
Page of

Early-onset preeclampsia: balancing maternal and neonatal morbidity 

Early-onset preeclampsia: balancing maternal and neonatal morbidity
Early-onset preeclampsia: balancing maternal and neonatal morbidity

Manju Chandiramani

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 July 2021

Characterized by new-onset hypertension and proteinuria, pre-eclampsia is thought to complicate approximately 4 % of pregnancies. This case of severe early-onset pre-eclampsia necessitating delivery at 27 weeks’ gestation illustrates the difficulty in balancing risk of prematurity-related complications with maternal risk. Alongside the case, the case provides a comprehensive overview of the evidence for use of drug agents to prevent pre-eclampsia (aspirin and calcium), as well as those commonly prescribed to treat hypertension and pre-eclampsia. Furthermore, the risk of complications in the postnatal period is highlighted.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.